|
|
Other links at Articles > Cardiology |
| 1. |
"Consider" Candesartan for Diabetic Retinopathy
|
|
|
Despite meeting none of the primary end points in the three DIRECT studies in diabetic retinopathy, the angiotensin receptor blocker candesartan could still be considered a treatment option in certain patients with this condition, say the trial authors and accompanying editorialists. Heartwire
|
|
|